Most PCS patients still ill in year two
In a German nested case-control follow-up, 67.6% of PCS cases remained symptomatic at phase 2 while 78.5% of recovered controls stayed well; symptoms stayed nonspecific without lab evidence of viral persistence.
Source
Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study
Study at a glance
- Design
- Case-control — Nested phase-2 outpatient assessment of PCS cases vs age/sex-matched recovered controls
- N
- N=1558 · 982 PCS cases and 576 matched recovered controls; median 8.5 months after phase 1
- Population
- Adults 18–65 with prior questionnaire-defined PCS or recovery in southwestern Germany
- Outcome
- Persistence of PCS symptoms and associated clinical/lab profiles
Structured fields used in claim comparison tables when every cited study has a complete layer.
What they did
Nested case-control follow-up (phase 2) of adults aged 18–65 from an earlier population questionnaire study: 982 PCS cases and 576 age- and sex-matched recovered controls underwent comprehensive outpatient assessment (neurocognitive, cardiopulmonary exercise, laboratory testing) at four university centres in southwestern Germany, a median 8.5 months after phase 1.
What they found
At phase 2, 67.6% of phase-1 PCS patients had persistent PCS; 78.5% of phase-1 recovered participants stayed free of PCS-related problems. Persistent cases were less often never smokers (61.2% vs 75.7%) and more often obese (30.2% vs 12.4%). Symptom patterns stayed dominated by fatigue, exercise intolerance, and cognitive complaints; labs did not support viral persistence, EBV reactivation, adrenal insufficiency, or increased complement turnover.
The limits
What it doesn't show
Volunteers may differ from non-participants; controls were symptom-free at phase 1, not uninfected comparators. Objective deficits do not pinpoint a single mechanism, and findings may not generalize beyond working-age southwestern Germany.
Key terms
- PCS
- Post-acute sequelae of COVID-19/post-COVID-19 syndrome—ongoing symptoms after acute SARS-CoV-2 infection.
- Nested case-control
- Cases and controls drawn from a defined earlier cohort (phase 1 questionnaire), then reassessed in phase 2.
- Phase 2 assessment
- Follow-up clinic visit with neurocognitive, cardiopulmonary exercise, and laboratory testing.
- PEM
- Post-exertional malaise; history of PEM linked to more severe symptoms and objective signs.
- Persistence
- Still meeting PCS case definition at phase 2 after qualifying as a case at phase 1.
- Cardiopulmonary exercise testing
- Objective measure of exercise capacity used alongside self-reported symptoms.
Flashcards
Research intelligence for this paper
See its role on concept claims, tensions it is part of, placement history, and related discoveries.
Quiz yourself
Phase-2 persistence rate among phase-1 PCS cases?
Common questions
Did most PCS patients recover by year two?
No—67.6% of phase-1 PCS cases still had persistent PCS at phase 2.
Did recovered people stay well?
Most did: 78.5% of phase-1 recovered participants remained free of PCS-related health problems.
What symptoms dominated?
Fatigue, exercise intolerance, and cognitive complaints; patterns stayed essentially similar and nonspecific.
Did labs show viral persistence?
Findings did not support viral persistence, EBV reactivation, adrenal insufficiency, or increased complement turnover as relevant mechanisms.
More on Wellbeing